PT-141 (Bremelanotide) 10mg Nasal Spray Kit
$60.00
Add to cartHigh Purity: Precision-engineered materials for laboratory research.
Research Focused: Quality controlled for dependable research applications.
Fast Shipping: Free delivery on qualifying orders over $250.
MELANOTAN I
Packaging: 1 Box (10 Vials)
Melanotan I (MT-I), also known as Afamelanotide, is a synthetic analog of the naturally occurring melanocortin peptide hormone α-MSH (alpha-melanocyte stimulating hormone). It is designed to stimulate melanin production in the skin, supporting gradual pigmentation and enhanced resistance to ultraviolet (UV) exposure. Compared to Melanotan II, MT-I is often studied for its more selective melanocortin receptor activity and reduced side effect profile.
Key Research Applications
• Skin Pigmentation – Supports the development of a natural-looking tan with reduced UV exposure.
• Photoprotection – Investigated for its ability to increase resistance to sun-related skin damage.
• Skin Health Research – Explored in studies related to photosensitivity disorders and UV tolerance.
• Wellness Support – May assist in maintaining even skin tone and pigmentation balance. Clinical Findings
Contents: Lyophilized Melanotan 1 (Afamelanotide) peptide
Purity: ≥98% (typical, batch-dependent)
Quantity: 10 mg
Storage: Store in a cool, dry environment; refrigerate after reconstitution
Molecular Class: Synthetic peptide (melanocortin analog)
Each batch is manufactured using industry-standard synthesis protocols and undergoes quality control procedures to verify identity and purity. Documentation such as Certificates of Analysis (COAs) may be available upon request for select batches.
This product is intended strictly for laboratory research and educational purposes only.
Not for human or veterinary use.
Not intended to diagnose, treat, cure, or prevent any disease.
All information provided is for informational and research reference purposes only and should not be interpreted as medical advice. NordWellness does not make any claims regarding therapeutic applications or outcomes.